Actively Recruiting
Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer
Led by Umeå University · Updated on 2022-11-30
300
Participants Needed
1
Research Sites
314 weeks
Total Duration
On this page
Sponsors
U
Umeå University
Lead Sponsor
U
University Hospital, Linkoeping
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study aims to assess overall survival, quality of life and resection rates in locally advanced pancreatic cancer
CONDITIONS
Official Title
Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed or suspected invasive pancreatic primary tumor
- Tumor classified as borderline resectable or locally advanced disease according to NCCN guidelines
You will not qualify if you...
- Suspected endocrine tumor
- Suspected non-pancreatic periampullary tumor
- Distant metastasis
- Age under 18 years
- Unable to understand verbal or written information interfering with informed consent or treatment
- Mental or organic disorder interfering with informed consent or treatments
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Surgical Clinic at Umeå University Hospital
Umeå, Sweden, 90185
Actively Recruiting
Research Team
O
Oskar Franklin, MD/PhD
CONTACT
A
Agneta Karhu
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here